Philip Morris International Announces FDA Authorization of IQOS 3 for Sale

Must Read

How To Block Your Bank Account And SIM Card In Case Of Emergency

Losing your phone and wallet or having them stolen can be very frustrating. However, in case that happens to...

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of Access Bank Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number which usually identifies both the bank and the branch where an account is...
- Advertisement -

The U.S. Food and Drug Administration (FDA) today confirmed that IQOS 3, Philip Morris International’s electrically heated tobacco system, is appropriate for the protection of public health and has authorized it for sale in the United States.

FDA’s decision follows an assessment of a premarket tobacco product application (PMTA) filed with the agency in March 2020.

Philip Morris International Announces FDA Authorization of IQOS 3 for Sale Brandspurng
IQOS 3 Device (Photo: Business Wire)

The IQOS 3 device contains a number of technological advancements, compared to a previously authorized IQOS device, including longer battery life and quicker recharge between uses.

In its decision, the FDA noted that:

  • International survey data reviewed by the agency found no evidence of increased uptake of IQOS by youth or young adults, while use patterns available for a previously authorized version of IQOS within the U.S. have not raised new concerns regarding product use in youth and young adults.

Altria_Philip Morris International Announces FDA Authorization of IQOS 3 for Sale Brandspurng

Commenting on the FDA’s announcement, André Calantzopoulos, PMI’s Chief Executive Officer, said:

- Advertisement -

“The agency’s decision to authorize IQOS 3 for sale in the U.S. is another important step forward for the tens of millions of American men and women who currently smoke. In just five years, approximately 11.7 million people around the world have stopped smoking and switched to IQOS, and we believe bringing a more modern version of IQOS to the U.S. will only accelerate switching by adults who smoke.”

He added, “The order is subject to the same comprehensive commercialization requirements set in the April 2019 PMTA marketing orders for IQOS 2.4, which aim to maximize the opportunity for adults to switch from cigarettes while minimizing unintended use. We, along with our licensee Altria, are committed to guarding against unintended use and fully support FDA’s focus on protecting youth.”

Read Also:  Philip Morris defends IQOS safety vs regular cigarettes

On July 7, 2020, the FDA authorized IQOS 2.4 as a modified risk tobacco product (MRTP), finding that an IQOS exposure modification order is appropriate to promote the public health.

The IQOS 3 PMTA authorization is independent of the MRTP authorization for the IQOS 2.4 device. PMI expects to file an application seeking a modified exposure marketing order for the IQOS 3 device.

- Advertisement -

On April 30, 2019, the FDA authorized IQOS 2.4 for sale in the U.S. through the issuance of premarket tobacco authorization marketing orders.

IQOS is available in the U.S. market through an exclusive license with Altria Group, Inc.

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, and its shareholders.

PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S.

- Advertisement -

In addition, PMI ships a version of its IQOS Platform 1 device and its consumables to Altria Group, Inc. for sale under license in the U.S., where the U.S. Food and Drug Administration (FDA) has authorized their marketing as a modified risk tobacco product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health.

- Advertisement -
Philip Morris International Announces FDA Authorization of IQOS 3 for Sale - Brand SpurPhilip Morris International Announces FDA Authorization of IQOS 3 for Sale - Brand Spur

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Philip Morris International Announces FDA Authorization of IQOS 3 for Sale - Brand SpurPhilip Morris International Announces FDA Authorization of IQOS 3 for Sale - Brand Spur

Latest News

Local Equities Market Falls by 0.23% amid Renewed Bearish Activity

Nigeria’s equities benchmark index fell today by 0.23% to 40,963.14 points. Year to date return and market capitalization settled...

Price of Maize Set to Crash, 300,000MT of Maize for Release in February 2021

About 300,000 metric tonnes of maize are soon to be released into the Nigerian market from strategic anchors under the Anchor Borrowers' Programme (ABP)...

MTV Base premieres “Celebrity Bumps”, a new reality TV show starring BBNaija’s Mike Edwards and wife, Perri

MTV Base has announced the African premiere of its UK hit reality show, Celebrity Bumps. The debut season dubbed “Mike + Perri Celebrity Bumps”...

Nigeria Economy in 2021: Tough times, tough takes!

Covid-19 took its toll on the Nigerian economy in 2020, after the FGN imposed widespread nationwide lockdowns in Q2-2020 to contain the virus. The...

Ekiti State To Unveil Nigeria’s Largest Snail Farm

In line with the Ekiti State Government’s policy of encouraging private investments in the state, the State Governor, Dr. Kayode Fayemi, will be commissioning...
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -Philip Morris International Announces FDA Authorization of IQOS 3 for Sale - Brand SpurPhilip Morris International Announces FDA Authorization of IQOS 3 for Sale - Brand Spur